Summary
Economic appraisal of genetics services is usually limited to consideration of financial costs and benefits, but this can generate misunder-standings about the aims of these services. We propose a general framework for economic analysis that includes non-financial costs and benefits, and the concept of genetic fitness.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Angastiniotis, M. A., Kyriakidou, S. and Hadjiminas, M. How thalassaemia was controlled in Cyprus.World Health Forum 7 (1986) 291–297
Attanasio, E., Gallanello, R. and Rossi-Mori, A. Analisi costi-benefici di uno intervento preventivo per la talassemia. In:La Preventione delle Malattie Microcitemice. Editioni Minerva Medica, Roma, 1980, pp. 277–284
Chamberlain, J. Human benefits and costs of a national screening programme for neural tube defects.Lancet 2 (1978) 1293–1296
Drummond, M. F.Principles of Economic Appraisal in Health Care. Oxford Medical Publications, Oxford University Press, Oxford, 1980.
Fraser, G. R. The short-term reduction in birth incidence of recessive diseases as a result of genetic counselling after the birth of an affected child.Hum. Hered. 22 (1972) 1–6
Gill, M., Murday, V. and Slack, J. An economic appraisal of screening for Down's syndrome in pregnancy using maternal age and serum alpha fetoprotein concentration.Soc. Sci. Med. 24 (1986) 725–731.
Hagard, S. and Carter, F. A. Preventing the births of infants with Down's syndrome: a cost-benefit analysis.Br. Med. J. 1 (1976) 753–756
Henderson, J. B. Measuring the benefits of screening for neural tube defects.J. Epidemiol. Commun. Health 36 (1982) 214–219
Loukopolous, D. (ed.).Prenatal Diagnosis of Thalassaemia and the Haemoglobinopathies. CRC Press Inc., Boca Raton, Florida, 1988
Modell, B. and Berdoukas, V.The Clinical Approach to Thalassaemia. Grune and Stratton, New York, 1984
Modell, B. and Petrou, M. Comprehensive management of thalassaemia major.Arch. Dis. Child. 58 (1983) 1026–1030
Modell, B., Ward, R. H. T. and Fairweather, D. V. I. Effect of introducing antenatal diagnosis on the reproductive behaviour of families at risk for thalassaemia major.Br. Med. J. 2 (1980) 737
Modell, B., Kuliev, A. K. and Wagner, M.Community Genetics Services in Europe. WHO Regional Office for Europe, Public Health In Europe Series. (In press)
Old, J. M., Fitches, A., Heath, C., Thein, S. L., Weatherall, D. J., Warren, R., McKenzie, C., Rodeck, C. H., Modell, B., Petrou, M. and Ward, R. H. T. First trimester fetal diagnosis for the haemoglobinopathies: report on 200 cases.Lancet 2 (1986) 763–766
Ostrowsky, J. T., Lippman, A. and Scriver, C. R. Cost-benefit analysis of a thalassemia disease prevention programme.Am. J. Public Health 75 (1985) 732–736
Royal College of Physicians.Prenatal Diagnosis and Genetic Screening: Community and Service Implications. The Royal College of Physicians of London, 1989
Sadovnik, A. D. and Baird, P. A. A cost-benefit analysis of prenatal diagnosis of Down syndrome and neural tube defects in older mothers.Am. J. Med. Genet. 10 (1981) 367–378
World Health Organization. Advisory Group on Hereditary Diseases.Community Approaches to the Control of Hereditary Diseases. Unpublished WHO document HMG/WG/85.4, 1985. [Can be obtained free of charge from, The Hereditary Diseases Programme, WHO, Geneva, Switzerland]
World Health Organization.The Haemoglobinopathies in Europe. WHO Regional Office for Europe, unpublished report IPC/MCH 110 (1987). (Can be obtained free of charge from: Maternal and Child Health Division, WHO Regional Office for Europe, 8 Scherfigsvej, DK-2100, Copenhagen, Denmark)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Modell, B., Kuliev, A.M. Services for thalassaemia as a model for cost-benefit analysis of genetics services. J Inherit Metab Dis 14, 640–651 (1991). https://doi.org/10.1007/BF01797934
Issue Date:
DOI: https://doi.org/10.1007/BF01797934